Alembic Pharma receives USFDA approval for Telmisartan and Amlodipine
Alembic Pharmaceuticals has received USFDA approval for its Telmisartan and Amlodipine tablets in the strengths of 40mg/5 mg, 40mg/10 mg, 80mg/5 mg and 80mg/10 mg, […]
Month: November 2016
Shilpa Medicare receives USFDA approval for Azacitidine injection
Shilpa Medicare has received USFDA approval of Azacitidine injection which is used in the treatment of myelodysplastic syndrome. Myelodysplastic syndrome is a condition that affects […]
Marksans Pharma receives USFDA approval for Paricalcitol
Marksans Pharma has received USFDA approval for Paricalcitol capsules which are used for treating hyper parathyroidism. The Paricalcitol capsules are therapeutically equivalent to the reference […]
Jubilant Life Sciences receives USFDA approval for Darifenacin
Jubilant Life Sciences has received the final USFDA approval for Darifenacin Extended-Release Tablets, used for the treatment of urinary incontinence. The company has received Abbreviated […]